Mapspeople (MAPS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jun, 2026Executive summary
Q1 2025 saw recognized revenue rise 4% year-over-year to DKK 15 million, with EBITDA improving 19% to a loss of DKK 7 million, but overall growth slowed due to global turmoil and trade uncertainty impacting new contract signings and ARR growth.
Total ARR grew 12% year-over-year to DKK 59.8 million, with MapsIndoors ARR up 19% to DKK 46.3 million, though this was a significant deceleration from prior years.
Apex Group Technologies, backed by Round13, agreed to acquire at least 51% of shares, injecting DKK 39 million in new capital and initiating a transition to private ownership and delisting from Nasdaq First North.
Customer decision delays and internal focus on the acquisition process contributed to slower growth.
Financial highlights
MapsIndoors product revenue and ARR grew 19% year-over-year, with recognized revenue for Q1 at DKK 15 million.
Net revenue retention improved to 105% in Q1, up from 103% in Q4.
Customer acquisition cost payback period remained within the 12–18 month target, currently at 16–17 months.
12-month rolling revenue reached DKK 63 million, up from DKK 46 million a year ago; 12-month rolling EBITDA loss reduced from DKK 51 million to DKK 28 million.
EBIT for Q1 2025 was negative DKK 10.6 million, improved from negative DKK 11.9 million year-over-year.
Outlook and guidance
Management remains cautiously optimistic, focused on ARR growth, cost optimization, and expects to meet full-year guidance despite slower net ARR growth.
DKK 39 million capital injection from Apex is expected to support continued growth and expansion.
Latest events from Mapspeople
- Strong ARR and revenue growth, improved EBITDA, and a DKK 36M capital raise nearly complete.MAPS
Q2 202423 Jan 2026 - Q2 2024 saw strong ARR and revenue growth, improved EBITDA, and a major capital raise in progress.MAPS
Q2 202423 Jan 2026 - Q3 2024 saw record revenue, improved EBITDA, and lower ARR guidance after a capital raise.MAPS
Q3 202414 Jan 2026 - Q3 2024 saw 9% ARR and 38% revenue growth, improved EBITDA, and a strong cash boost.MAPS
Q3 202414 Jan 2026 - 54% revenue growth, halved EBITDA loss, and strong ARR outlook for 2025.MAPS
Q4 202426 Dec 2025 - 54% revenue growth, halved EBITDA loss, and 2025 targets ARR growth of 33-35% with strong outlook.MAPS
Q4 202426 Dec 2025